About Clintrax Global
Clintrax Global is a Healthcare company based in Cary (United States) founded in 2013, and was acquired by WIRB-Copernicus Group in March 2016. Provider of clinical trial training, patient engagement, data monitoring, and regulatory services. Clintrax Global has completed 1 acquisition, including Acorn Applications. Clintrax Global offers products and services including IRBNet, ClinSphere, and Connexus. Its focus areas include Biopharma Outsourcing and Diversified. Its legal entity in India is Clintrax Global Research Private Limited (U74900TN2015PTC103479). Its competitors include ANI Pharmaceuticals, Red Nucleus and Aptar.
Company details
Clintrax Global was founded in 2013 and is headquartered in Cary, United States. Operations are centered in the clinical research sector, where services including training for trial participants, patient engagement initiatives, data monitoring processes, and regulatory compliance support are delivered. These offerings assist pharmaceutical and biotechnology firms through standard web-based access via clintraxglobal.com, with a focus on operational efficiency in trial management.
- Headquarters Cary, United States
- Stage Acquired
- SectorsHealthcare
- Website clintraxglobal.com
- Acquired by WIRB-Copernicus Group (Mar 2016)
- Legal Name Clintrax Global Research Private Limited
- Date of Incorporation 31 Dec, 2015
- Jurisdiction Chennai, Tamil Nadu, India
- Indian entity net loss-₹23,564
FY 2020 · 0% margin
- Indian entity EBITDA-₹15,000
FY 2020 · 0% margin
- Investors
- Investments & Acquisitions
- Acquired byWIRB-Copernicus Group
(Mar 2016)
Associated legal entities of Clintrax Global
Clintrax Global operates through Clintrax Global Research Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2020) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Clintrax Global Research Private Limited CIN U74900TN2015PTC103479 | Active | 31 Dec 2015 | Chennai, Tamil Nadu | 3 | View details |
Products & Services of Clintrax Global
Clintrax Global offers a comprehensive portfolio of products and services, including IRBNet, ClinSphere, and Connexus.
Platform for managing ethical reviews of clinical studies
System for enhancing participant enrollment in trials
Tool for benchmarking and performance management
Investors in Clintrax Global
Clintrax Global has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include WIRB-Copernicus Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Regulatory and ethical review services for clinical research are provided. | 2012 | wcgclinical.com | Princeton, United States |
Investor details for Clintrax Global
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Clintrax Global Research Private Limited (Clintrax Global)
Clintrax Global Research Private Limited is the primary company behind Clintrax Global. The board of Clintrax Global Research Private Limited currently have 3 directors; the longest-serving is Sheetal Londhe Kamlesh, appointed in 2015. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sheetal Londhe Kamlesh DIN 07308975 | Director | 31 Dec 2015 | 10 yrs 10 mo | Clintrax Global Research Private Limited |
| Jill Marie Johnston DIN 08621828 | Additional Director | 02 Dec 2019 | 6 yrs 11 mo | Clintrax Global Research Private Limited |
| Marco Vincent Capasso DIN 08621820 | Additional Director | 02 Dec 2019 | 6 yrs 11 mo | Clintrax Global Research Private Limited |
Financials of Clintrax Global
Figures of Clintrax Global Research Private Limited, the primary company behind Clintrax Global, for FY 2020. Net loss was -₹23,564 (0% margin). EBITDA was -₹15,000 (0% margin). Revenue has grown at a compounded annual rate of -100% over three years.
- -₹23,564Net loss · 0% margin
- -₹15,000EBITDA · 0% margin
- ₹1 LakhPaid-up capital
- -100%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Clintrax Global Research Private Limited are on its company page.
Detailed financial statements for Clintrax Global
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Clintrax Global
Clintrax Global has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Acorn Applications.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cloud-based analytic solutions for clinical research are developed. | acornapplications.com | Raleigh, United States | 2013 | Aug 2016 | •••• |
Complete acquisition details for Clintrax Global
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Clintrax Global
3 dated milestones of Clintrax Global across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Clintrax Global is founded.
- Exit Acquired by WIRB-Copernicus Group.
- Acquisition Acquires Acorn Applications.
Competitors of Clintrax Global
Clintrax Global has 3 listed competitors in our database. They include ANI Pharmaceuticals, Red Nucleus and Aptar.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| anipharmaceuticals.com | 1996 | Baudette, United States | 600 | Branded and generic prescription drugs are developed, manufactured, and marketed. | ||
| rednucleus.com | 2014 | Yardley, United States | 176 | Advisory, scientific, and medical communications provided for pharmaceutical industry. | ||
| aptar.com | 1992 | Crystal Lake, United States | 232 | Regulatory support, brand differentiation, and prototyping services are provided. |
Detailed competitors of Clintrax Global
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Clintrax Global (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Clintrax Global
Clintrax Global was founded in 2013.
Clintrax Global is headquartered in Cary, United States. It is registered at Cary, North Carolina, United States.
Clintrax Global was founded in 2013 and is headquartered in Cary, United States. Operations are centered in the clinical research sector, where services including training for trial participants, patient engagement initiatives, data monitoring processes, and regulatory compliance support are delivered. These offerings assist pharmaceutical and biotechnology firms through standard web-based access via clintraxglobal.com, with a focus on operational efficiency in trial management.
Clintrax Global's top competitors include ANI Pharmaceuticals, Aptar and Red Nucleus.
Clintrax Global offers IRBNet, ClinSphere, and Connexus.
Clintrax Global has made 1 acquisition, including Acorn Applications.
Clintrax Global has 1 investor. Key investors include WIRB-Copernicus Group.
Clintrax Global operates through Clintrax Global Research Private Limited.
Yes. Clintrax Global was acquired by WIRB-Copernicus Group in March 2016.
The legal entities of Clintrax Global currently have 3 directors, including Jill Marie Johnston, Marco Vincent Capasso, Sheetal Londhe Kamlesh.